covid-19 vaccine

Peter J. Pitts, a former Food and Drug Administration associate commissioner, and current president of the Center for Medicine in the Public Interest joined NBCLX and debunked many of the fears people have expressed about taking a COVID-19 vaccine.

Now that the COVID-19 vaccine is here people have questions. We have answers. Peter Pitts, a former policy advisor with the FDA, joined NBCLX to address some of the more pressing concerns many have with the possibility of receiving the vaccine for both themselves and their loved ones.

IBM security researchers say they have detected a cyberespionage effort using targeted phishing emails to try to collect vital information on the World Health Organization’s initiative for distributing COVID-19 vaccine to developing countries.

The U.K. has become the first country to approve the Pfizer and BioNTech COVID-19 vaccine and will begin distributing doses to the public next week. Former FDA Associate Commissioner Peter Pitts says the U.S. will be right behind the U.K., predicting hundreds of millions of doses will be ready to go before Christmas.

Two mRNA vaccines from Pfizer and Moderna are nearing final approval. But how do they work? Michael Teng, an associate professor at the University of South Florida’s College of Medicine, joined LX News to explain the role mRNA plays in making these vaccines work and why they should be trusted.

The White House held a teleconference with the nation’s governors Monday as Illinois’ top doctor discussed vaccine rollout plans with hospital leaders across the state. NBC 5’s Mary Ann Ahern reports.

Both Pfizer and Moderna have submitted their vaccines as part of an approval process that could take weeks.

Moderna says its COVID-19 vaccine was 94.1% effective during trials and that they will submit a request for emergency use authorization to the FDA.

Several coronavirus vaccines are now in final stages for approval, but doctors are already worried that the public won’t want to take them. Dr. Paul Biddinger, who sits on the Massachusetts governor’s advisory group for COVID-19 vaccines, joined LX News to explain the many safety steps required for the vaccines to be approved for the general public and when to...

With multiple effective vaccines on the way, Johns Hopkins’ Dr. Joshua Sharfstein says this winter season will be the “last big battle” we face against COVID-19, but that winning the fight and saving lives will require a redoubled effort by everyone.

With both the Moderna and Pfizer vaccines making headlines this week, we’re all wondering when we can sign up to get a dose. Dr. Ruth A. Karron, a research director at the Johns Hopkins Vaccine Initiative, joined LX News to explain how the vaccines are likely to get rolled out and why we all need to remain vigilant in the...

Illinois Department of Public Health Director Dr. Ngozi Ezike answers some questions on the COVID-19 vaccine progress, the case number surge in Illinois and how to have a safer Thanksgiving this year.

Hope could be on the horizon in the search for an effective COVID-19 vaccine thanks to countless researchers, epidemiologists, immunologists and … Dolly Parton?

Moderna and Pfizer have now both reported that their COVID-19 vaccines have been highly effective in trials. But how do they work, and what are the differences between the two? Benjamin Neuman, a professor of biological studies at Texas A&M, breaks down the specifics of both vaccines.

Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing COVID-19.

Moderna announced Monday that preliminary data from its phase 3 trial showed its coronavirus vaccine is more than 94% effective in preventing COVID-19. Dr. Bob Lahita, a clinical professor at New York Medical College and the Chairman of the Department of Medicine at St. Joseph’s Healthcare System, breaks down the “very exciting news,” and why March and April could be...

Dr. Anthony Fauci says he trusts Pfizer and the Food and Drug Administration and if the data is checked and approved, he would take the coronavirus vaccine.

Pfizer’s surprising news that its COVID-19 vaccine might offer more protection than anticipated is raising questions about exactly how the different shots will make it to market

Pfizer revealed Monday that early results from its coronavirus vaccine suggest the shots may be 90% effective at preventing COVID-19, putting the company on track to apply later this month for emergency-use approval from the Food and Drug Administration.

On the same morning Pfizer revealed early data on its coronavirus vaccine that suggests it may be 90% effective at preventing COVID-19, President-elect Joe Biden also revealed the members of his of coronavirus task force, which will put together a blueprint for fighting the pandemic.